iGMDRD65
Canonical SMILES: CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)C)O)N)O
InChI: InChI=1S/C27H29NO10/c1-10-22(30)14(28)7-17(37-10)38-16-9-27(35,11(2)29)8-13-19(16)26(34)21-20(24(13)32)23(31)12-5-4-6-15(36-3)18(12)25(21)33/h4-6,10,14,16-17,22,30,32,34-35H,7-9,28H2,1-3H3/t10-,14-,16-,17-,22+,27-/m0/s1
InChI Key: STQGQHZAVUOBTE-VGBVRHCVSA-N
Drug Class:
Anthracycline Topoisomerase InhibitorAnthracyclinesAnthracyclines and Related SubstancesAntibiotics, AntineoplasticAntineoplastic AgentsAntineoplastic and Immunomodulating AgentsBCRP/ABCG2 SubstratesCarbohydratesCardiotoxic antineoplastic agentsCytochrome P-450 Enzyme InducersCytochrome P-450 Enzyme InhibitorsCytotoxic Antibiotics and Related SubstancesEnzyme InhibitorsGlycosidesHydrocarbonsHydrocarbons, AromaticHydrocarbons, CyclicImmunosuppressive AgentsMyelosuppressive AgentsNaphthacenesP-glycoprotein/ABCB1 InducersP-glycoprotein/ABCB1 InhibitorsP-glycoprotein/ABCB1 SubstratesPolycyclic CompoundsPolycyclic Hydrocarbons, AromaticTopoisomerase II InhibitorsTopoisomerase InhibitorsDrug-model tissue-cancer distribution: Bubble Plot
Drug-gene pathway enrichments
Drug-gene GO enrichments
Drug-Gene: Aster Plot
Gene in drug-gene network: Network Plot

Models in Daunorubicin
Loading, please wait...
Model | Level | Reference ID | Tissue | Cancer | Drug | Clinical Response | Source | |
---|---|---|---|---|---|---|---|---|
No matching records found |